{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18565600", "DateCompleted": {"Year": "2008", "Month": "11", "Day": "24"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "06", "Day": "02"}], "Language": ["eng"], "ELocationID": ["10.1016/j.antiviral.2008.05.002"], "Journal": {"ISSN": "0166-3542", "JournalIssue": {"Volume": "80", "Issue": "1", "PubDate": {"Year": "2008", "Month": "Oct"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice.", "Pagination": {"StartPage": "62", "EndPage": "70", "MedlinePgn": "62-70"}, "Abstract": {"AbstractText": ["Oxyresveratrol, a major compound purified from Artocarpus lakoocha, a Thai traditional medicinal plant, was evaluated for its mechanism of action and therapeutic efficacy on cutaneous herpes simplex virus (HSV) infection in mice. The inhibitory concentrations for 50% HSV-1 plaque formation of oxyresveratrol, three clinical isolates, thymidine kinase (TK)-deficient and phosphonoacetic acid (PAA)-resistant HSV-1 were 19.8, 23.3, 23.5, 24.8, 25.5 and 21.7microg/ml, respectively. Oxyresveratrol exhibited the inhibitory activity at the early and late phase of viral replication and inhibited the viral replication with pretreatment in one-step growth assay of HSV-1 and HSV-2. Oxyresveratrol inhibited late protein synthesis at 30microg/ml. The combination of oxyresveratrol and acyclovir (ACV) produced synergistic anti-HSV-1 effect, as characterized by the isobologram of plaque inhibition. Mice orally treated with oxyresveratrol (500mg/kg/dose) dose at 8 h before and three times daily had significant delay in herpetic skin lesion development (P<0.05). Topical application of 30% oxyresveratrol ointment five times daily significantly delayed the development of skin lesions and protected mice from death (P<0.0001)."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand."}], "Identifier": [], "LastName": "Chuanasa", "ForeName": "Taksina", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Phromjai", "ForeName": "Jurairatana", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lipipun", "ForeName": "Vimolmas", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Likhitwitayawuid", "ForeName": "Kittisak", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Suzuki", "ForeName": "Mikiko", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pramyothin", "ForeName": "Pornpen", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hattori", "ForeName": "Masao", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shiraki", "ForeName": "Kimiyasu", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "4721-07-7", "NameOfSubstance": "puag-haad"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Herpes Simplex"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Herpesvirus 1, Human"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["chemistry"], "DescriptorName": "Moraceae"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Skin Diseases"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Stilbenes"}, {"QualifierName": [], "DescriptorName": "Thailand"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}, {"QualifierName": [], "DescriptorName": "Viral Plaque Assay"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "10", "Day": "31"}, {"Year": "2008", "Month": "4", "Day": "2"}, {"Year": "2008", "Month": "5", "Day": "5"}, {"Year": "2008", "Month": "6", "Day": "21", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "6", "Day": "21", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18565600", "10.1016/j.antiviral.2008.05.002", "S0166-3542(08)00291-X"]}}], "PubmedBookArticle": []}